IGA at ECRD 2024

IGA was represented at the 12th European Conference of Rare Diseases 2024 (ECRD) by its CEO Tanya Collin-Histed and Global Gaucher Connect Program volunteer Andre Balzekiene. Over 400 hundred medical specialists, representatives of patient and rare disease organisations gathered in Brussels on 15-16th of May to discuss not only the current needs of rare disease patients and caregivers but also challenges of further development, e.g. better financing of genetic trials or cross-border collaboration among doctors and hospitals.

The IGA poster, presented online at ECRD platform, introduced the Global Gaucher Connect Program (formerly known as Regional Managers Program) as the opportunity to globally connect and help the countries with no or very few patient advocacy.

The project started as a pilot in 2018, and covered four regions: South Asia, Eastern Europe and the Balkans, Central America, and the Caucasus and Central Asia. The volunteers have been working on improving awareness of Gaucher disease in their regions and conducted CMEs for healthcare professionals in Nepal (2019) a virtual CME on LSDs in South Asia (2021). In 2021 the RM programme was revised to 6 regions and 8 regional managers. In 2022/2023 the programme hosted educational webinars for Africa, Asia, Europe, Central America, with over 2000 people attending (most of them medical professionals).

The long term benefits of this program should include better awareness of Gaucher disease, more accurate data about numbers of Gaucher patients, their treatment and care. Through this program IGA is supporting humanitarian aid cases where needed.

With the European Parliament elections approaching on June 6-9, the importance of voting was emphasised at the conference. As a result of the topics discussed and issues raised in 2 days of the conference, an Open Letter addressed to the European Commission has been put together, calling on the next European leaders to maintain health at the forefront of future policies and programmes; develop a comprehensive European Action Plan for Rare Diseases; immediately address the most pressing needs of the rare disease population by integrating the actions “within reach”.

“As a mom of a Gaucher disease patient, I usually think about the challenges that we face locally: how to secure a treatment, how to support myself and others psychologically, how to help my son to get the best quality of life. ECRD helped me understand the bigger picture, how much of the future of the patient is decided at the European level: the shared data across countries helps to understand the rare and ultra-rare diseases better, the sufficient financing of genetic trials may result in new gene therapy or medicine, the cross-border cooperation of doctors, which specialise in rare diseases, can improve the quality of the treatment. It was an honour to represent IGA at the place where policy makers, pharma companies and patients meet. I’ve collected quite a few ideas, which work well for other rare diseases but could be easily applied to improve the journey of Gaucher patients”. – Andre Balzekiene

× How can I help you?